A Phase I Dose Finding Study of Panobinostat in Children with Hematologic Malignancies: Initial Report of TACL Study T2009-012 in Children with Acute Leukemia

John M. Goldberg(Nomura Holdings (Japan)), Julio C. Barredo(University of Miami), Julie R. Park(Seattle Children's Hospital), Maria Luisa Sulis(Columbia University Irving Medical Center), Cecilia Fu(University of Southern California), Jeannette Cassar(Children's Hospital of Los Angeles), Elena Eckroth(Children's Hospital of Los Angeles), Paul S. Gaynon(University of Southern California), Richard Sposto(Children's Hospital of Los Angeles), Naomi Winick(The University of Texas Southwestern Medical Center), Raymond J. Hutchinson(Children's Hospital of Los Angeles), Javier Oesterheld(Carolinas Medical Center), Jessica A. Pollard(Maine Medical Center), Nobuko Hijiya(Lurie Children's Hospital), Rebecca Gardner(Seattle Children's Hospital), Yoav H. Messinger(Children’s Minnesota - St. Paul Hospital), Julia Glade Bender(Columbia University Irving Medical Center), Victor Aquino(The University of Texas Southwestern Medical Center), Blythe Thomson(Epizyme (United States)), Bruce Bostrom(Minnesota West Community & Technical College), Thomas Manley(IGM Biosciences (United States)), Rajen Mody(University of Michigan)

Blood

December 6, 2014

Cited by 11

|Transplantation and Cellular Therapy|2018|3.6k

|Blood|2014|2.8k

|New England Journal of Medicine|2014|1.4k

|Nature Genetics|2013|1.2k

|Nature Genetics|2017|934

Related Papers